Purchase Order N4034521P0079
Award Date
9/10/21
Potential Completion Date
11/30/21
Potential Value
$343K
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
Naval Supply Systems Command
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Vietnam
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>The Department of the Navy Bureau of Medicine and Surgery awarded a $248,637.36 firm-fixed-price purchase order to Praesensbio LLC, a for-profit limited liability company, for sequence-based characterization of SARS. The contract has a performance period ending on September 26, 2023 and was awarded on September 26, 2022. The place of performance is Vietnam. No set-aside was used for this award.</p>
The Department of the Navy Bureau of Medicine and Surgery awarded a $9,275 purchase order to Miscellaneous Foreign Awardees - doing business as Federal Egov IAE Initiative - Generic Entity Identifier for D4085: SELECT-A-SIZE DNA CLEAN & CONCENT. The contract has a period of performance from June 28, 2023 through September 29, 2023 to be carried out in Peru on a firm fixed price basis. The Bureau of Medicine and Surgery supports the Navy and Marine Corps through the provision of healthcare...
The Department of the Navy, on behalf of the Secretary of the Navy and Chief of Naval Operations, has awarded a $12,270 firm fixed-price purchase order contract to Miscellaneous Foreign Awardees - doing business as Federal Egov IAE Initiative - Generic Entity Identifier. The contract calls for the delivery of BT sequence data with raw files (FASTQ 100K) for an Illumina MiSeq plateform. Performance will take place in Thailand over approximately one month, from September 9th to October 23rd, 2023....
This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company, was made by the Defense Health Agency, a defense agency within the U.S. Department of Defense. The $3,574,052.08 firm fixed-price purchase order is for a molecular assay-analyzer, associated reagents, maintenance, and consumables to support testing for respiratory, blood culture, gastrointestinal, and meningitis/encephalitis targets, including COVID-19, at the Naval Medical Center Portsmouth...
The Department of the Navy Bureau of Medicine and Surgery awarded a $39,873.00 firm fixed price purchase order to Biomeme, Inc., a for-profit manufacturer of goods, for the provision of a FRANKLIN REAL-TIME PCR THERMOCYCLER. This contract award, which was not set aside, has an anticipated completion date of October 30, 2020. Biomeme has previously provided real-time PCR thermocyclers, custom reagents, and other diagnostic products to various Department of Defense organizations, the Department of...
This federal contract award is to Illumina, Inc., a for-profit manufacturer, for a MiSeq System (CAT# SY-410-1003) under a firm fixed price purchase order from the Department of the Navy Bureau of Medicine and Surgery. The $120,089.00 award supports the National Interest Action Code for Coronavirus COVID-19 and does not use a set-aside designation. Illumina has previously delivered a range of genetic sequencing systems, reagents, and services to various federal agencies like the NIH, CDC,...
The U.S. Department of the Navy awarded a $247,371.53 firm-fixed-price purchase order contract to Praesensbio LLC, a for-profit limited liability company, for a "Sequence Based Detection Biothreat Agent" requirement. The contract has a period of performance through March 29, 2024 and was awarded on September 27, 2023 without a set-aside. The requirement was originally solicited as an 8(a) sole source opportunity. Based on the description, this contract appears to support the Department...
This is a firm fixed price delivery order awarded by the Department of the Navy Bureau of Medicine and Surgery to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, which does not have a set aside designation, is for the delivery of goods and services related to diagnostic testing equipment, reagents, and consumables, as well as associated maintenance and support services. The potential value of...
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for $97,678.20. The award provides Illumina's RNA sequencing products and reagents to support the Naval Health Research Center's (NHRC) laboratory work characterizing biological threats. The contract has a period of performance through December 1, 2021. This award is not associated with a set-aside program. Illumina has previously...
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Navy, to Cepheid Inc. for the provision of GeneXpert IV-2 CLIA diagnostic systems, printers, and associated equipment and services. The $79,625 contract award does not have a set-aside designation, as Cepheid was selected as the sole-source provider. The contract supports the Naval Health Research Center's (NHRC) requirement for molecular diagnostic equipment and consumables...